BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suárez-Sánchez FJ, Lequerica-Fernández P, Suárez-Canto J, Rodrigo JP, Rodriguez-Santamarta T, Domínguez-Iglesias F, García-Pedrero JM, de Vicente JC. Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression. Cancers (Basel) 2020;12:E1764. [PMID: 32630659 DOI: 10.3390/cancers12071764] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Struckmeier A, Radermacher A, Fehrenz M, Alansary D, Wartenberg P, Wagner M, Scheller A, Hess J, Moratin J, Freudlsperger C, Hoffmann J, Thurner L, Roemer K, Freier K, Horn D. TREM2 Is Associated with Advanced Stages and Inferior Prognosis in Oral Squamous Cell Carcinoma. Cancers 2022;14:4635. [DOI: 10.3390/cancers14194635] [Reference Citation Analysis]
2 Xue Y, Song X, Fan S, Deng R. The role of tumor-associated macrophages in oral squamous cell carcinoma. Front Physiol 2022;13:959747. [DOI: 10.3389/fphys.2022.959747] [Reference Citation Analysis]
3 Sun Q, Liu Q, Zhou X, Wang X, Li H, Zhang W, Yuan H, Sun C. Flavonoids regulate tumor-associated macrophages - From structure-activity relationship to clinical potential (Review). Pharmacol Res 2022;184:106419. [PMID: 36041653 DOI: 10.1016/j.phrs.2022.106419] [Reference Citation Analysis]
4 Ruiz-ranz M, Lequerica-fernández P, Rodríguez-santamarta T, Suárez-sánchez FJ, López-pintor RM, García-pedrero JM, de Vicente JC. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment. Front Immunol 2022;13:941351. [DOI: 10.3389/fimmu.2022.941351] [Reference Citation Analysis]
5 Hadjigol S, Shah BA, O’brien-simpson NM. The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes. Front Immunol 2022;13:894021. [DOI: 10.3389/fimmu.2022.894021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kondoh N, Mizuno-Kamiya M. The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas. Cancers (Basel) 2022;14:2884. [PMID: 35740551 DOI: 10.3390/cancers14122884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhou W, Du W, Li Y, Al-aroomi MA, Yan C, Wang Y, Zhang Z, Liu F, Sun C. The Overexpression of Fibronectin 1 Promotes Cancer Progression and Associated with M2 Macrophages Polarization in Head and Neck Squamous Cell Carcinoma Patients. IJGM 2022;Volume 15:5027-42. [DOI: 10.2147/ijgm.s364708] [Reference Citation Analysis]
8 Tian Y, Zhang L, Jin N, Wan Z, Zhang H, Zhang H, Zhang L. Clinical Response to Neoadjuvant Immunotherapy Combined with Targeted Therapy and Chemotherapy in Oral Squamous Cell Carcinoma: Experience in Three Patients. OTT 2022;Volume 15:353-9. [DOI: 10.2147/ott.s355349] [Reference Citation Analysis]
9 Peña-cardelles JF, Pozo-kreilinger JJ, Roncador G, Esteban-hernández J, Moro-rodríguez JE, Sastre-perona A, Castelo-fernández B, Cebrián-carretero JL. Prognosis Value of Immunoregulatory Molecules in Oral Cancer Microenvironment: An Immunohistochemical Study. Biomedicines 2022;10:710. [DOI: 10.3390/biomedicines10030710] [Reference Citation Analysis]
10 Dos Santos ES, Wagner VP, Cabral Ramos J, Lambert DW, Castilho RM, Paes Leme AF. Epigenetic modulation of the tumor microenvironment in head and neck cancer: Challenges and opportunities. Crit Rev Oncol Hematol 2021;164:103397. [PMID: 34146679 DOI: 10.1016/j.critrevonc.2021.103397] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Lequerica-Fernández P, Suárez-Canto J, Rodriguez-Santamarta T, Rodrigo JP, Suárez-Sánchez FJ, Blanco-Lorenzo V, Domínguez-Iglesias F, García-Pedrero JM, de Vicente JC. Prognostic Relevance of CD4+, CD8+ and FOXP3+ TILs in Oral Squamous Cell Carcinoma and Correlations with PD-L1 and Cancer Stem Cell Markers. Biomedicines 2021;9:653. [PMID: 34201050 DOI: 10.3390/biomedicines9060653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bruna F, Scodeller P. Pro-Tumorigenic Macrophage Infiltration in Oral Squamous Cell Carcinoma and Possible Macrophage-Aimed Therapeutic Interventions. Front Oncol 2021;11:675664. [PMID: 34041037 DOI: 10.3389/fonc.2021.675664] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 De Keukeleire SJ, Vermassen T, Hilgert E, Creytens D, Ferdinande L, Rottey S. Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives. Cancers (Basel) 2021;13:1714. [PMID: 33916646 DOI: 10.3390/cancers13071714] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Kalogirou EM, Tosios KI, Christopoulos PF. The Role of Macrophages in Oral Squamous Cell Carcinoma. Front Oncol 2021;11:611115. [PMID: 33816242 DOI: 10.3389/fonc.2021.611115] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
15 Ries J, Agaimy A, Wehrhan F, Baran C, Bolze S, Danzer E, Frey S, Jantsch J, Möst T, Büttner-Herold M, Wickenhauser C, Kesting M, Weber M. Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia. Biomedicines 2021;9:194. [PMID: 33669300 DOI: 10.3390/biomedicines9020194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Suárez-Sánchez FJ, Lequerica-Fernández P, Rodrigo JP, Hermida-Prado F, Suárez-Canto J, Rodríguez-Santamarta T, Domínguez-Iglesias F, García-Pedrero JM, de Vicente JC. Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment. Cancers (Basel) 2021;13:395. [PMID: 33494389 DOI: 10.3390/cancers13030395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Economopoulou P, Kotsantis I, Psyrri A. Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer. Cancers (Basel) 2020;12:E3377. [PMID: 33203092 DOI: 10.3390/cancers12113377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]